Eli Lilly Weighs Employer Growth Potential Against Fresh Actos Legal Risk [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Eli Lilly (NYSE:LLY) launched its Employer Connect platform to expand access to its obesity medicine Zepbound through U.S. employers and program administrators. A federal court certified a National Third-Party Payor class action lawsuit related to the diabetes drug Actos, naming Eli Lilly and Takeda as defendants. Eli Lilly, a major U.S. pharmaceutical company, is leaning into employer-based coverage with Employer Connect as obesity treatments receive more attention in health benefit design. For investors, this connects to a broader effort by drugmakers to work directly with payors and benefits teams to address access and cost questions around newer therapies. At the same time, the certified Actos class action introduces a legal overhang that payors and shareholders will likely monitor, particularly regarding any potential financial exposure and brand impact. Tak
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Lilly (LLY) Down 3.7% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (LLY) had its "buy" rating reaffirmed by Deutsche Bank Aktiengesellschaft.MarketBeat
- Factbox-Top pharma companies racing to launch a weight-loss pill [Yahoo! Finance]Yahoo! Finance
- GLP-1 drugs linked to lower addiction risk, study finds [USA TODAY]USA TODAY
- GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026 [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 3/6/26 - Form PRE
- 2/19/26 - Form 4
- 2/18/26 - Form 4
- LLY's page on the SEC website